FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,276 letters match. Newest first.
-
DrugsOptikem International Inc.
FDA warns Optikem International after inspection found inadequate aseptic controls for sterile ophthalmic drugs, including contamination and validation failures.
High risk -
DrugsLaboratorio Magnachem International
FDA cited Laboratorio Magnachem for CGMP failures and unapproved, misbranded Broncochem cough/cold drugs after a 2023 inspection.
High risk -
DrugsPremier Manufacturing Products, LLC
FDA warns Premier Manufacturing over Tianaa tianeptine products sold as unapproved new drugs.
High risk -
DrugsOzempen.com
FDA warned Ozempen.com it sells unapproved, misbranded semaglutide pens to U.S. consumers online.
High risk -
DrugsSun Pharmaceutical Industries Limited
FDA cited Sun Pharmaceutical Industries for inadequate cleaning and maintenance at its Dadra drug plant, risking cross-contamination, and for weak investigations.
High risk -
DrugsSani-Care Salon Products, Inc.
FDA warns Sani-Care Salon Products over CGMP failures in hand sanitizer manufacturing, including inadequate quality oversight and testing.
High risk -
DrugsGFA Production Xiamen Co., Ltd.
GFA Production Xiamen failed CGMP for drugs, including process validation, cleaning, and lab controls.
High risk -
DrugsLandy International
FDA found Landy International’s OTC hand sanitizers adulterated after a 2023 inspection revealed missing testing, unsafe water, and data integrity failures.
High risk -
DrugsAqualex Co., Ltd.
Aqualex, a Korean contract manufacturer, was cited for manufacturing failures and an unapproved OTC sunscreen with misleading labeling.
High risk -
DrugsAngela D. Ritter, M.D.
FDA warns Dr. Angela Ritter over unauthorized dosing of an investigational drug and missing ethics-board review.
High risk -
DrugsTCT Nutraceuticals SDN. BHD
FDA warns TCT Nutraceuticals over manufacturing-rule failures in OTC hand sanitizer, including no methanol testing.
High risk -
DrugsFancystage Unipessoal, LDA
FDA warned Portugal OTC drug maker Fancystage Unipessoal of repeated CGMP failures, untested ingredients, unvalidated processes and misbranded fluoride mouthwash.
High risk -
DrugsCosmetic Solutions, LLC
FDA warns Cosmetic Solutions over manufacturing failures and unapproved OTC drugs at Boca Raton plant.
High risk -
DrugsAruba Aloe Balm N.V.
Aruba Aloe Balm N.V. made OTC drugs with methanol-contaminated ethanol and failed CGMP, prompting recall and import alert.
High risk -
DrugsBiomic Sciences, LLC dba ION Intelligence of Nature
Biomic Sciences' nasal spray was grossly contaminated with microorganisms, and FDA also found manufacturing and labeling violations.
High risk -
DrugsWard Smelling Salts
FDA warns Canadian maker Ward Smelling Salts that its ammonia inhalant products are unapproved new drugs sold illegally in the U.S.
High risk -
DrugsSafari Stem Cell, LLC
FDA warned Safari Stem Cell for selling unapproved stem cell animal drugs made without required CGMP controls, including sterility testing.
High risk -
DrugsSeatex, LLC
FDA: Seatex made hand sanitizer on equipment also used for floor cleaner and skipped ingredient identity tests.
High risk -
DrugsCentral Admixture Pharmacy Services, Inc.
FDA warned sterile drug compounder Central Admixture Pharmacy Services (Phoenix) that dirty areas and weak sterility testing made its drugs adulterated.
High risk -
DrugsNatuzen Co., Ltd.
Natuzen Co., Ltd. failed drug manufacturing rules for OTC products including Atoren Hand Sanitizer, with no methanol testing, cleaning validation, or quality unit.
High risk -
DrugsGrupo Quimico SRL
FDA warns Uruguay contract testing lab Grupo Quimico over data integrity failures, including unreported failing HPLC results.
High risk -
DrugsWestwood Laboratories LLC
FDA warned Westwood Laboratories after an inspection found inadequate investigations, raw material testing, lab controls, and water/cleaning controls for OTC drugs.
High risk -
DrugsCohere Beauty
FDA cites Cohere Beauty for unvalidated OTC drug manufacturing and inadequate quality oversight at its Santa Fe Springs facility.
Medium -
DrugsSeatex, LLC
Seatex, LLC made OTC hand sanitizer drugs with inadequate current good manufacturing practice (CGMP), including shared equipment with industrial chemicals and missing component testing.
High risk -
DrugsCentral Admixture Pharmacy Services, Inc.
FDA warned Central Admixture Pharmacy Services' Allentown outsourcing facility over sterile drug contamination and CGMP failures.
High risk -
DrugsVintage Chemical Inc.
FDA warned Vintage Chemical after an inspection found over-the-counter hand soap and sanitizer made on equipment shared with industrial cleaners.
High risk -
DrugsKevin R. Bender, M.D./DBC Research Corporation
Clinical investigator Kevin R. Bender failed to secure a controlled investigational drug, and 110 kits were stolen.
High risk -
DrugsGlobal Cosmetics Company Limited
FDA warns Global Cosmetics over manufacturing quality failures in OTC hand sanitizer, including no methanol testing of ethanol.
High risk -
Drugswww.dashpct.com
FDA warned www.dashpct.com over selling unapproved semaglutide drugs with unlawful labeling to U.S. consumers online.
High risk -
DrugsZen Enterprises LLC
Zen Enterprises failed to correct drug listing files that named a manufacturer not involved in making its balms and hand sanitizers.
Low -
DrugsDr Sankunni’s Ayurvedic Research Foundation Private Ltd.
Dr Sankunni's Ayurvedic Research Foundation failed to correct drug listing and registration errors for its balms and hand sanitizer.
Low -
DrugsNorthern VA Compounders PLLC, dba Akina Pharmacy
FDA warns Akina Pharmacy over unsafe production of compounded drugs and sterility risks.
High risk -
DrugsC&T Dream Co., Ltd.
C&T Dream failed CGMP (current good manufacturing practice) for its over-the-counter Dry Skin Healing Ointment, including identity testing and process validation.
High risk -
DrugsNatco Pharma Limited
FDA warned Natco Pharma of adulterated drugs after finding dirty equipment and weak investigations at an India plant.
High risk -
DrugsMaster Paints & Chemicals Corp.
FDA warned Master Paints & Chemicals Corp. over inadequate testing and quality oversight for OTC drugs including hand sanitizer.
High risk -
DrugsJiangsu Meifan Biotechnology Co. Ltd.
FDA cites Jiangsu Meifan Biotechnology for OTC drug manufacturing-rule failures and import alert.
High risk -
DrugsFirstCham Co., Ltd.
FDA warns FirstCham over current good manufacturing practice violations and misbranding of Soo'Ae hand sanitizing wipes.
High risk -
DrugsKilitch Healthcare India Limited
FDA warns Kilitch Healthcare India over insanitary sterile drug manufacturing and falsified environmental monitoring data.
High risk -
DrugsAntaria Pty. Ltd.
FDA warned Antaria Pty. Ltd. about manufacturing quality failures in its active drug ingredient, including poor out-of-specification investigations and testing.
High risk -
DrugsBodywell Natural Skin Care Inc.
FDA warned Bodywell Natural Skin Care that its OTC hand sanitizer and Dermalere creams were adulterated due to CGMP failures and unapproved drug claims.
High risk -
DrugsBetone S.A. de C.V.
FDA warns Betone S.A. de C.V. over manufacturing violations for OTC antiseptic wipes, including subpotent active and missing glycerin safety tests.
High risk -
DrugsSky Bank Media, LLC dba Painless Tattoo Cream Co.
FDA warned Painless Tattoo Cream Co. that its numbing cream and spray are unapproved new drugs with excess lidocaine.
High risk -
DrugsTattoo Numbing Cream Co.
Tattoo Numbing Cream Co. sold Signature Tattoo Numbing Cream and Miracle Numb Spray as unapproved drugs for tattooing.
High risk -
DrugsDermal Source, Inc.
FDA warned Dermal Source that five topical anesthetic products are unapproved and misbranded drugs with lidocaine above OTC limits.
High risk -
DrugsSeeNext Venture, Ltd.
FDA warns SeeNext Venture over unapproved, misbranded NumbSkin lidocaine creams sold online.
High risk -
DrugsTKTX Company
TKTX Company sells unapproved, misbranded lidocaine numbing creams online at illegal concentrations for cosmetic procedures.
High risk -
DrugsIndelicare DBA INKEEZE
FDA warns Indelicare that its INKEEZE lidocaine numbing gel, spray and foam soap are unapproved new drugs sold outside OTC limits.
High risk -
DrugsBret R. Rutherford, M.D.
FDA warned Dr. Bret R. Rutherford for enrolling ineligible patients in two drug studies by skipping required antidepressant washout.
High risk -
DrugsNew York State Psychiatric Institute IRB
FDA warned New York State Psychiatric Institute's review board it failed to report serious research problems and reviewed drug studies without required nonscientific member.
High risk -
DrugsAmmonia Sport Inc.
Ammonia Sport Inc. sells three smelling-salt stimulant drugs as unapproved new drugs and misbranded products, FDA says.
High risk